Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SUZ12 pseudogene 1 (SUZ12P1) is a pseudogene, meaning it resembles a functional gene (SUZ12) but does not encode a functional protein product. SUZ12 itself plays a critical role in gene silencing as part of the Polycomb repressive complex 2, influencing histone methylation and transcriptional repression in processes such as development and cancer[2][3][5]. However, SUZ12P1 does not produce a functional protein, and therefore is not considered a therapeutic target, receptor, enzyme, or a clinically relevant biomarker in the current biomedical literature[7]. If the intention was to refer to the functional SUZ12 gene or protein, that should be clarified, as SUZ12 is an established target in epigenetics and cancer biology, but SUZ12P1 lacks that molecular functionality[2][3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SUZ12 pseudogene 1 (SUZ12P1).